Skip to main content

Light sensitivity

perception effect

valenceadversefrequencycommontemporalacute

AI-inferred — this entry was drafted by AI and has not yet been verified against primary sources. A sourced revision is planned.

Light sensitivity is a heightened responsiveness to ambient light in which ordinary illumination registers as uncomfortable, painful, or visually overwhelming.

As a drug effect it is acute and dose-proportional, easing as the substance wears off; it is distinct from clinical photophobia, which persists independent of any single episode. It ranges from mild squinting in bright conditions to sharp ocular discomfort and an urgent need to seek shade or close the eyes.

Light sensitivity is a common adverse perceptual effect across several drug classes. It is most commonly induced at moderate to high doses under psychedelics such as LSD, psilocybin mushrooms, and LSA, and under stimulants such as modafinil, adrafinil, and armodafinil; it also appears under deliriants such as myristicin.

phenomenology

Light sensitivity is felt as an involuntary recoil from brightness: ordinary overhead lighting registers as too sharp, sunlight becomes glaring, and screens acquire a piercing quality they would not normally have. The eyes narrow or water without deliberate effort, and sustained exposure produces a pressing ache behind the orbits.

Attending to a bright source compounds the response — the longer the gaze lingers, the more insistent the aversion becomes. At higher doses, particularly under psychedelics, ambient light can feel all-encompassing and visually relentless, sharpening the pull toward dimmer environments.

mechanism

Light sensitivity arises through different pathways depending on the drug class:

  • Psychedelics — act on 5-HT2A receptors, raising sensory gain across visual cortex; incoming light signals are amplified well beyond their ordinary weight, making normal brightness feel excessive.
  • Stimulants — drive pupil dilation through sympathomimetic activity, enlarging the aperture through which light enters the eye and intensifying the effective brightness of any scene.
  • Deliriants — produce pronounced mydriasis through anticholinergic blockade of the pupillary constrictor, leaving the eye structurally unable to limit incoming light.

How much each pathway contributes in a given case is not fully understood.

variability

Who experiences it, and how strongly, varies widely. Higher doses raise both its likelihood and intensity across all three classes. Brightly lit settings — sunlit outdoor environments, uncovered windows, screens used in dark rooms — amplify it considerably, while dim or shaded surroundings reduce it almost entirely.

People with lighter irises may notice it more readily due to less baseline pigmentation filtering peripheral light. Expectation plays a limited role; the response is largely pupillary and physiological. Moving to a darker space brings relief quickly regardless of the substance involved.

experience reports

No experience reports yet. Be the first to contribute.

First-person accounts of subjective effects, timing, and outcomes — submitted for harm reduction.

AI-generated · claude-sonnet-4-6 · reviewed

Harm-reduction reference — not medical advice.

Last updated May 25, 2026Report an issue